Livermore

Kinnevik AB (publ)

SEC CIK
0001766574

Holdings, Q3 2025

Positions as of Sep 30, 2025, filed Nov 4, 2025.SEC

Positions
1
0 vs. Q2 2025
Total value
$65.56M
−$2.42M (−3.6%) vs. Q2 2025

Compare with Q2 2025: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q2 2025.

Kinnevik AB (publ) holdings in Q3 2025
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
RXRXRECURSION PHARMACEUTICALS INCL A13,434,171$65.56M100.00%00.0%UnchangedView

13F filings by quarter

Kinnevik AB (publ) 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q3 2025Nov 4, 20251$65.56Mvs. Q2 2025SEC
Q2 2025Aug 13, 20251$67.98Mvs. Q1 2025SEC
Q1 2025Apr 28, 20251$71.07Mvs. Q4 2024SEC
Q4 2024Jan 23, 20251$80.48Mvs. Q3 2024SEC
Q3 2024Oct 15, 20241$78.46Mvs. Q2 2024SEC
Q2 2024Jul 8, 20241$89.29Mvs. Q1 2024SEC
Q1 2024Apr 15, 20241$103.74Mvs. Q4 2023SEC
Q4 2023Feb 2, 20241$102.6Mvs. Q3 2023SEC
Q3 2023Oct 6, 20231$79.6Mvs. Q2 2023SEC
Q2 2023Jul 25, 20231$77.73Mvs. Q1 2023SEC
Q1 2023Apr 14, 20232$74.55Mvs. Q4 2022SEC
Q4 2022Feb 1, 20233$177.29Mvs. Q3 2022SEC
Q3 2022Oct 25, 20222$119.31Mvs. Q2 2022SEC
Q2 2022Aug 8, 20222$176.07Mvs. Q1 2022SEC
Q1 2022May 12, 20222$479.43Mvs. Q4 2021SEC
Q4 2021Feb 14, 20222$778.55M–SEC